Therapeutic review: antibiotic prophylaxis for bacterial endocarditis

Area of Science:

• Infectious Diseases
• Cardiology
• Pharmacology

Background:

• Clinical practice for antibiotic prophylaxis frequently deviates from established guidelines by organizations like the British Society for Antimicrobial Chemotherapy (BSAC) and the American Heart Association (AHA).
• Healthcare practitioners express confusion regarding antibiotic prophylaxis, indicating a need for clearer guidance and updated recommendations.
• Bacterial endocarditis prophylaxis guidelines are primarily based on animal studies and understanding human pathogenesis, lacking robust human clinical trials.

Purpose of the Study:

• To present current recommendations for antibiotic prophylaxis to address confusion among practitioners.
• To highlight the limitations of existing guidelines, which are not based on human trials.
• To emphasize that optimal prophylaxis cannot entirely prevent bacterial endocarditis.

Main Methods:

• Review of current recommendations from authoritative bodies.
• Analysis of the basis for these recommendations (animal studies, pathogenesis).
• Discussion of the limitations due to the absence of controlled human trials.

Main Results:

• Significant discrepancies exist between recommended antibiotic prophylaxis practices and actual clinical application.
• Existing guidelines for bacterial endocarditis prophylaxis are not supported by human clinical trials, necessitating a flexible approach.
• Even with optimal prophylaxis, bacterial endocarditis remains a significant concern, with only an estimated 10% of cases being theoretically preventable in developed countries.

Conclusions:

• Current antibiotic prophylaxis practices for bacterial endocarditis require updated guidance due to widespread confusion and deviation from recommendations.
• The lack of human trials necessitates a non-rigid approach to prophylaxis, acknowledging its limitations in preventing all cases of endocarditis.
• Optimal antibiotic prophylaxis is crucial but cannot eliminate bacterial endocarditis, underscoring the importance of ongoing research and clinical vigilance.